Matthew Barth, MD
Basic profileMatthew Barth is an Oncology physician affiliated with Roswell Park Cancer Institute.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingIndustry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year202511 payments$18,117
- Bayer Healthcare Pharmaceuticals Inc.Program year20251 payment$1,541
- SpringWorks Therapeutics, Inc.Program year202515 payments$1,432
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Similar KOLs
Other experts from the same institution or the same specialty.
Jens Hillengass, MD
Roswell Park Cancer Institute
Steven Green, MD
Roswell Park Cancer Institute
Nathaniel Ivanick, MD
Roswell Park Cancer Institute
Shalana O'Brien, MD
Roswell Park Cancer Institute
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”